In the recent SARS-CoV-2 pandemic, public health experts have emphasized testing,
tracking infected people, and tracing their contacts as an effective strategy to reduce the …

The global coronavirus disease 2019 (COVID-19) has presented major challenges for
clinical laboratories, from initial diagnosis to patient monitoring and treatment. Initial …

Molecular diagnosis of COVID-19 primarily relies on the detection of RNA of the SARS-CoV-
2 virus, the causative infectious agent of the pandemic. Reverse transcription polymerase …

Background The recent emergence of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has resulted in a rapid proliferation of serologic assays. However, little is …

ABSTRACT The Elecsys Anti-SARS-CoV-2 immunoassay (Roche Diagnostics) was
developed to provide accurate, reliable detection of antibodies to severe acute respiratory …

Abstract Background Commercially available SARS-CoV-2 serological assays based on
different viral antigens have been approved for the qualitative determination of anti-SARS …

Abstract The Elecsys® Anti-SARS-CoV-2 S immunoassay (Roche Diagnostics International
Ltd, Rotkreuz, Switzerland) has been developed for the detection of antibodies to the severe …

(1) Background: Health workers (HWs) are at high risk of acquiring SARS-CoV-2 (Severe
Acute Respiratory Syndrome Coronavirus 2) infections. Therefore, health authorities further …

Background In the context of the COVID-19 pandemic, numerous new serological test
systems for the detection of anti-SARS-CoV-2 antibodies rapidly have become available …

Objective This study aimed to evaluate the diagnostic performance of the Abbott Architect
SARS-CoV-2 IgG assay in COVID-19 patients. Methods Residual sera from 177 …